Gasping Already

There is no market for Bharat Biotech’s nasal vaccine, a late entrant

- BY NEETU CHANDRA SHARMA

BHARAT BIOTECH LAUNCHED its Covid-19 nasal vaccine on January 26, 2023. The vaccine is expected to face major hurdles in finding a market in India as well as globally.

Dubbed as a game changer in preventing the spread of coronavirus, Bharat Biotech's nasal vaccine, called iNCOVACC is the first intranasal vaccine in the world to have received approval as both a primary vaccine for Covid-19 and a booster.